Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Editorial: New Insights: Developments in Laboratory Testing for the Diagnosis and Monitoring of Endocrine Related Disorders and Metabolic Disease

Editorial: New Insights: Developments in Laboratory Testing for the Diagnosis and Monitoring of Endocrine Related Disorders and Metabolic Disease

Authors: Gounden V, Tanpaiboon P

Citation: Front Endocrinol (Lausanne). 2024 Nov 29;15:1524950. doi: 10.3389/fendo.2024.1524950.

Specialties: Cardiology, Endocrinology

Related content

Audio Podcast
The Cardiometabolic Approach: A Solution to Modern Disease Risk Assessment
Audio Podcast
Instant Insight: Metabolic Risk Panel
Audio Podcast
Laboratory Testing for the Diagnosis and Management of Thyroid Disorders
On-Demand Webinar
Cardiovascular Clinical Conversations: Inflammatory Markers for Defining Cardiovascular Risk

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.